Skip to content

FDA Warns Of HIV Drug Mix-Up


The U.S. Food and Drug Administration said Thursday that bottles of HIV drug Ziagen may have been mislabeled as Combivir, another HIV drug.

The FDA and GlaxoSmithKline, which makes both drugs, said it appears the bottles were tampered with by a third party that used counterfeit labels to mislead readers about the contents, WebMD reported Thursday.

12 April 2007

Read the full story at postchronicle.com.

Scroll To Top